Bio Green Med Solution, Inc. 8-K

What Happened
Bio Green Med Solution, Inc. (BGMS) filed a Current Report on Form 8‑K on March 30, 2026 to announce its financial results for the fourth quarter ended December 31, 2025. The company furnished a press release reporting those quarterly results (Exhibit 99.1) and included the required XBRL cover page (Exhibit 104). The filing also includes the company’s forward‑looking statements caution about risks and uncertainties.

Key Details

• Filing date: March 30, 2026 (Form 8‑K).
• Period covered: Fourth quarter ended December 31, 2025.
• Disclosure items reported: Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
• Exhibits: Exhibit 99.1 — press release dated March 30, 2026; Exhibit 104 — Interactive XBRL cover page.

Why It Matters
An 8‑K reporting quarterly results is material for investors because it provides the company’s latest operating and financial information that can affect valuation and trading decisions. The Regulation FD disclosure indicates BGMS publicly furnished the results to the market (via press release). Investors should read the attached press release and the company’s periodic SEC filings (10‑K, 10‑Q) for full financial details and the risk factors referenced in the forward‑looking statement language.